利润表
ELEDON PHARMACEUTICALS, INC.
ELDN
业绩概览
点击表格中任意一行将其添加到图表
单位：百万美元
| 指标 | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
营业收入
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
营业成本
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
毛利润
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
营业费用
|
83.25 | 70.58 | 43.00 | 88.43 | 36.87 | 18.47 | 16.05 | 14.06 | 13.12 | 38.12 | 45.26 | 23.46 |
|
研发费用
|
66.27 | 51.96 | 30.31 | 27.08 | 23.74 | 6.13 | 8.13 | 6.82 | 2.02 | 25.02 | 32.64 | 14.58 |
|
销售、一般及行政费用
|
16.98 | 18.61 | 12.69 | 12.70 | 13.13 | 10.05 | 6.06 | 7.24 | 11.10 | 13.10 | 12.62 | 8.89 |
|
其他营业费用
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
营业利润
|
-83.25 | -70.58 | -43.00 | -88.43 | -36.87 | -18.47 | -16.05 | -14.06 | -13.12 | -38.12 | -45.26 | -23.46 |
|
营业外收入
|
-37.67 | -34.82 | -2.67 | -0.46 | -0.01 | 4.75 | - | - | - | - | - | 0.17 |
|
利息收入
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
利息支出
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
其他营业外收入/支出
|
4.22 | 3.92 | 2.67 | 0.46 | 0.01 | 0.08 | 0.04 | -0.01 | 0.01 | - | - | 0.16 |
|
税前利润
|
-45.58 | -35.75 | -40.33 | -87.97 | -36.86 | -23.22 | -16.01 | -14.07 | -13.12 | - | - | - |
|
所得税费用
|
0.04 | 0.43 | 0.00 | 0.00 | -2.35 | -0.40 | - | - | - | - | - | - |
|
少数股东损益
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
净利润
|
-45.62 | -36.18 | -40.33 | -87.97 | -34.51 | -22.81 | -16.01 | -14.07 | -13.12 | -37.96 | -45.09 | -23.30 |
补充资料
每股数据、派生项目及其他——不属于利润表
除特别注明外，单位均为百万美元
| 指标 | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
折旧与摊销
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-83.25 | -70.58 | -43.00 | -88.43 | -36.87 | -18.46 | -16.04 | -14.05 | -13.10 | -38.12 | -45.26 | -23.46 |
|
基本每股收益
|
-0.52 | -0.75 | -1.64 | -6.16 | - | - | - | - | - | - | - | - |
|
稀释每股收益
|
-0.52 | -0.75 | -1.64 | -6.16 | - | - | - | - | - | - | - | - |
|
加权平均股数
|
81.84 | 48.54 | 24.62 | 14.29 | - | - | - | - | - | - | - | - |
|
稀释加权平均股数
|
81.84 | 48.54 | 24.62 | 14.29 | - | - | - | - | - | - | - | - |
|
综合收益
|
-45.62 | - | - | - | - | - | - | - | - | -37.91 | -45.14 | - |